Edition:
United States

People: Belle International Holdings Ltd (1880.HK)

1880.HK on Hong Kong Stock

6.11HKD
10:27pm EDT
Change (% chg)

HK$-0.01 (-0.16%)
Prev Close
HK$6.12
Open
HK$6.11
Day's High
HK$6.12
Day's Low
HK$6.10
Volume
1,551,955
Avg. Vol
25,869,458
52-wk High
HK$6.15
52-wk Low
HK$4.07

Chan, Yu Ling 

Mr. Chan Yu Ling (Abraham) is Non-Executive Independent Director of Belle International Holdings Limited. He was appointed as a Director in October 2006. Mr. Chan is a chartered engineer in the United Kingdom, a professional engineer in Ontario, Canada and is currently an executive director, the chairman, the chief executive officer, the founder, chairman of nomination committee and member of scientific advisory committee of PuraPharm Corporation Limited (a company listed on the Stock Exchange, stock code: 1498). Mr. Chan is also currently a member of the Institution of Structural Engineers in the United Kingdom, a fellow of Hong Kong Institute of Directors, a committee member of the Chinese People’s Political Consultative Conference in Guangxi Zhuang Autonomous Region in the PRC, the former President and Council Member of the Modernized Chinese Medicine International Association Limited, a member of the Chinese Medicine Development Committee, and a former member of the Commission on Strategic Development (Commission Economic Development and Economic Cooperation with the Mainland) and part-time member of the Central Policy Unit of The Government of Hong Kong Special Administrative Region. Mr. Chan graduated from the University of Toronto in Canada with a Bachelor’s degree in applied science in 1982.

Basic Compensation

Total Annual Compensation, CNY 150,000
Restricted Stock Awards, CNY --
Long-Term Incentive Plans, CNY --
All Other, CNY --
Fiscal Year Total, CNY 150,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Yiu Tang

--

Baijiao Sheng

6,670,000

Fang Sheng

4,327,000

King Loy Tang

4,170,000

Wu Yu

3,483,000

Zhao Li

--
As Of  28 Feb 2016